Disruption of the complex pathways of the 12 cranial nerves can occur at any site along their course, and many, varied pathologic processes may initially manifest as dysfunction and neuropathy. Radiographic imaging (computed topography or magnetic resonance imaging) is frequently used to evaluate cranial neuropathies; however, indications for imaging and imaging method of choice vary considerably between the cranial nerves. The purpose of this review is to provide an analysis of the diagnostic yield and the most clinically appropriate means to evaluate cranial neuropathies using radiographic imaging. Using the PubMed MEDLINE NCBI database, a total of 49,079 articles' results were retrieved on September 20, 2014. Scholarly articles that discuss the etiology, incidence, and use of imaging in the context of evaluation and diagnostic yield of the 12 cranial nerves were evaluated for the purposes of this review. We combined primary research, guidelines, and best practice recommendations to create a practical framework for the radiographic evaluation of cranial neuropathies. September 2014) results were retrieved on September 20, 2014 by completing the following 13 independent, broad search queries: olfactory nerve, optic nerve, oculomotor nerve, trochlear nerve, trigeminal nerve, abducens nerve, facial nerve, vestibulocochlear nerve, glossopharyngeal nerve, vagus nerve, recurrent laryngeal nerve, accessory nerve, and hypoglossal nerve. Data collection and analysis. All published articles were scrutinized by two authors for exclusion and inclusion, with specific predetermined criteria. Inclusion criteria included: (1) full-text articles, (2) human subjects, and (3) English language. Exclusion criteria included: (1) commentaries, (2) correspondence, (3) letters to the editor, and (4) case reports.
Introduction
The 12 cranial nerves innervate both sensory and most functional components of the head and neck, with their afferent and efferent connections traversing the meninges, subarachnoid space, bony structures of the cranium, and superficial soft tissues. Disruption of these complex pathways can occur at any site along their course, and many, varied pathologic processes may initially manifest as cranial nerve dysfunction and neuropathy.
Radiographic imaging (computed topography [CT] or magnetic resonance imaging [MRI] ) is frequently used to evaluate cranial neuropathies. However, indications for imaging and the imaging method of choice vary, not only between the cranial nerves but also according to presentation of the neuropathy and patient characteristics. The purposes of this review are to provide (1) an analysis of the most clinically appropriate radiographic imaging method to evaluate pathologic etiologies affecting the 12 cranial nerves that result in neuropathy and (2) the diagnostic yield imaging presents to a wide range of clinicians. While this review does not detail new findings, our aim was to create a practical framework for the radiographic evaluation of cranial neuropathies.
Materials and methods
Types of studies. All scholarly articles that discuss the etiology, incidence, and use of imaging in the context of evaluation and diagnostic yield of the 12 cranial nerves were included.
Search strategy. Using the PubMed MEDLINE NCBI database, a total of 49,079 articles (January 1970 through Titles and abstracts for all the remaining studies were reviewed and evaluated, with a total of 1,772 citations identified which had a direct relation to cranial nerve disease etiology, incidence, and radiographic imaging. Extracted information focused on: (1) incidence of cranial nerve palsies, and (2) evidence-based CT, MRI, positron emission tomography (PET), and ultrasound (US) imaging evaluation of cranial nerve neuropathies.
The article selection process used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement as a guideline and is outlined in the figure. This material was supplemented, as deemed necessary, with targeted searches to address specific needs identified in writing this review through April 2015.
The definitions for evidence-based summary statements are listed in table 1, which is a combination of previously published definitions. 1, 2 Summary recommendation statements reflect both the quality of evidence and the balance of benefit and harm to the patient and society when such a statement is followed.
Levels of evidence assigned to references were based on definitions outlined in table 1 and corroborated when possible through use of the American College of Radiology Appropriateness Criteria for Cranial Neuropathies and databases such as DynaMed and UpToDate. Our summary statements are not intended to supersede professional judgment but rather to act as a tool to aid an individual physician's discretion in a particular clinical circumstance.
Results
Results and summary recommendation statements can be found in table 2.
Olfactory nerve (I). The first cranial nerve is an extracranial extension of the brain's white matter tracts, where collection and subsequent discrimination of extracranial sensory information can be achieved. Olfactory dysfunction may be broadly divided into two pathophysiologic entities: conductive (e.g., sinonasal inflammatory disease and obstructive sinonasal masses) and sensorineural (e.g., postinfectious, trauma, iatrogenic, age-related, and neurodegenerative diseases such as Alzheimer or Parkinson disease) 3 (2a) .
The prevalence of dysosmia in the general population is estimated at 5.6% and is up to 16% in the elderly. Approximately two-thirds of olfactory dysfunction is due to prior upper respiratory infection (40.2%), head trauma (39.3%), or sinonasal disease (6.3%) 4 (1b).
Diagnostic principles. Signs and symptoms of olfactory nerve palsy include anosmia, hyposmia, hyperosmia, and olfactory hypesthesia/hyperesthesia. The mechanism, onset, and time course of the initial olfactory disturbance may yield significant information with regards to its underlying etiology. An immediate loss suggests either peripheral or central sensorineural injury, most likely secondary to trauma. Intermittent loss can be indicative of an intranasal inflammatory process 5 (2a) . A gradual loss can reflect the development of a degenerative process or a progressive obstructive lesion within the olfactory region or more central neural structures.
Nasal endoscopy, either flexible or rigid, should be performed, with specific attention to the area of the olfactory cleft. The nasal cavity should be inspected for the presence of neoplastic masses, polyps, or mucosal lesions 6 (1a). In a study by Seiden and Duncan, nasal endoscopy appeared to play a crucial role in evaluating dysosmic patients, with over half the cases (51%) having detectable pathology not discernible with a nasal speculum 7 (1b).
Medical imaging. Medical imaging can be invaluable in understanding the basis of several smell and taste disturbances. CT is the most useful and initial cost-effective technique to assess craniofacial trauma and sinonasal tract inflammatory disorders. CT imaging is superior to MRI in the evaluation of acute craniofacial trauma of bony structures adjacent to the olfactory pathways or at a chronic stage when bone disruption of the cribriform plates resulting in CSF leakage is suspected 8 (2a).
Figure. Flow chart outlines the publication selection process.
guidelines for radiographic iMaging of cranial neuropathies MRI is the method of choice for evaluating soft tissue, in this case, the olfactory system and cortical parenchyma. In a study by Decker et al, 44 .3% of all MR scans were found to be normal, 40.2% had an incidental imaging finding unrelated to dysosmia, and 25.4% had an imaging finding that explained the dysosmia 9 (1c). The most common incidental findings on MRI scans were small vessel white-matter disease (21.1%), benign intracranial mass (12.2%), and maxillary or sphenoid sinusitis (6.5%). The most common causal finding was occult frontoethmoid sinusitis (18.3%). However, these findings had not been previously noted on prior clinical endoscopy. In addition, MRI scans for idiopathic anosmia or hyposmia demonstrated an intracranial neoplasm in 4.9% of cases 9 (1c).
In a similar study by Hoekman and colleagues, only 4.6% of patients with idiopathic olfactory loss demonstrated a detectable abnormality on MRI, of which 0.8% were directly attributable to olfactory dysfunction 10 (1b). Furthermore, in a 2014 study, Rudmik et al concluded that in patients who have no identifiable cause after a thorough history and who have negative findings for preceding viral illness or head trauma, and after physical examination and nasal endoscopy, obtaining no additional imaging is the most cost-effective decision. 11 
The overall cost of the MRI strategy in the Rudmik study was $2,400, whereas for the no-imaging strategy the overall cost was $86.61, which is supported by the incremental cost-effectiveness ratio (ICER) and willingness-to-pay (WTP) ratio 11 (2c) . As a result, MRI is best reserved for specific situations, such as congenital cases (e.g., Kallmann syndrome), concern for neoplastic lesions such as olfactory groove meningiomas, or for those patients with other neurologic symptoms concerning for central nervous system (CNS) lesions. However, evidence demonstrates a relatively low yield of MRI for actionable findings when done routinely and has been shown to not be cost-effective. Nevertheless, when imaging is indicated, MRI remains the gold standard for central causes of dysosmia at the skull base, where beam-hardening artifacts and partial volume effects often obscure CT studies 11,12 (2c, 2b) .
Summary. Clinicians should not routinely obtain MRI in adult patients with olfactory dysfunction who have no identifiable cause after a thorough history, physical exam, negative findings for preceding viral illness or head trauma, and nasal endoscopy. MRI remains the gold standard for central causes of dysosmia and is best reserved for specific concerns, or for those patients with other neurologic symptoms concerning for CNS lesions 11,12 (2c, 2b) . Optic nerve (II). Given its unique anatomic location, the second cranial nerve is naturally vulnerable to a wide variety of pathologic processes that affect both the central and peripheral nervous systems, ranging from inflammation, ischemia, infection, compression, infiltration, hereditary metabolic dysfunction, and trauma 13, 14 (1a, 2a). There is a diverse and heterogeneous range of pathology that requires management by a multidisciplinary team involving both otolaryngology and ophthalmology (e.g., orbital complications secondary to rhinosinusitis, Graves orbitopathy [GO], and traumatic optic neuropathy [TON]).
Rhinosinusitis continues to be the most common cause of orbital inflammation and infection, especially in children. While rare, unfortunately about 15 to 30% of cases complicated by a subperiosteal abscess will develop visual sequelae, even with aggressive medical and surgical intervention 15-19 (1a, 3a, 1b, 1b, 3a) . GO is the most common extrathyroidal manifestation of Graves disease 20,21 (2a, 2a), and approximately 50% of patients with Graves disease will develop orbital manifestations 22 (2a) .
Optic neuropathy, a less common but important complication of GO, has a reported occurrence rate ranging from 2 to 8% 21,23-26 (2a, 1a, 1a, 1a, 1b). TON can be classified as either direct or indirect. Direct TON is the result of anatomic disruption of the optic nerve (e.g., penetrating eye injuries) 23, 27 (1a, 1a), while indirect TON is the result of the transmission of force to the optic canal and orbital apex from a distant site (e.g., blunt trauma) 23, 27 (1a, 1a).
Diagnostic principles. Signs and symptoms of optic nerve palsy include blindness, hemianopia, and quadrantanopia. In cases of a complete lesion, the loss of the pupillary light reflex (direct response) in the eye on the injured side and loss of the pupillary light reflex (consensual response) in the opposite eye can be evident when shining a light in the affected eye. Conversely, shining a light in the normal, unaffected eye will result in a pupillary light reflex (direct response) in that eye and a consensual response in the affected eye.
Medical imaging. CT scanning is the diagnostic imaging modality of choice in the management of patients who have TON or postseptal complications of sinusitis such as subperiosteal abscess. Imaging for postseptal complications of sinusitis may be repeated after 48 hours if the patient's condition does not improve.
A recent study used lateral displacement of the medial rectus muscle of at least 2 mm as a diagnostic criterion for a subperiosteal abscess 18 (1b). However, CT scans have their limitations in the diagnosis of sinonasal disease, especially in children. Mucosal changes tend to persist, despite the resolution of clinical disease, with one study reporting incidental soft tissue changes in up to 50% of subjects without sinus disease 28, 29 (1b, 1b). Additionally, CT scans have been found to correlate with surgical findings in only 84% of orbital complications of sinusitis and can miss up to 50% of intracranial (IC) complications 15,17,30 (1a, 1b, 1b) .
MRI is the diagnostic study of choice for evaluating IC complications of sinusitis including cavernous sinus thrombophlebitis. MRI is superior to CT in identifying marrow space abnormalities such as edema or osteomyelitis, inflammation of the meninges, extra-axial empyemas, and early cerebritis 31 (2a). In patients who have orbital complications of sinusitis, MRI should be performed if fever recurs after an appropriate initial response to the antibiotic, if there are changes in the patient's mental status, or when CT findings suggest but cannot confirm intracranial spread of disease 15, 32 (2b, 1a).
All patients with GO who are being considered for active surgical intervention should have a CT scan of their paranasal sinuses for surgical planning, although imaging is not required in all cases of GO. Signs that may be apparent on CT scan include excess retro-orbital fat, enlargement of the extraocular muscles, and crowding of the orbital apex 26, [33] [34] [35] (1b, 1a, 1b, 2b). Orbital CT may detect subclinical enlargement of the extraocular muscles on the contralateral side in 50 to 90% of patients 36 (2a) . As an adjunct to a CT scan, MRI allows for more accurate visualization of the optic nerve and extraocular muscles, as well as potential determination of disease activity 23, 24, 33, 37 (1a, 1a, 1a, 1a).
In patients with optic atrophy and optic neuritis, MRI of the orbits is the imaging modality of choice to evaluate for orbital and/or visual pathway masses as well as multiple sclerosis 37,38 (1a, 1a) . Patients with papilledema and high clinical suspicion of pseudotumor cerebri with potential secondary atrophy of the optic nerve, both MRI of the brain and MR venogram may reveal imaging findings such as transverse sinus stenosis, an empty sella, and optic nerve head flattening and protrusion.
Summary. In patients with orbital complications of sinusitis, a CT should be performed initially; if symptoms fail to resolve (including worsening mental status) or suspected IC spread, MRI becomes an appropriate adjuvant study 15,32 (1a, 2b) . Patients with GO who are being considered for surgical management require CT imaging 23, 24, 33, 37 (1a, 1a, 1a, 1a). MRI should be reserved for patients with suspected optic atrophy and optic neuritis secondary to etiologies such as multiple sclerosis or pseudotumor cerebri 37,38 (1a, 1a) .
Oculomotor nerve (III). Today, most acquired cases of adult oculomotor palsy are ischemic in nature (secondary to diabetes and/or atherosclerosis), and they khaku, patel, zacharia, goldenBerg, Mcginn tend to resolve completely in a few months. Similarly, congenital cases of oculomotor nerve palsy, as well as those occurring later in life due to intracranial aneurysms and head injury, also have been known to partially recover 39 (3b) .
In a study of 1,400 patients by Keane, the most common causes of all third nerve palsies across all ages were due to trauma (26%), neoplasia (12%), diabetic nerve ischemia (11%), aneurysm (10%), iatrogenic (10%), infection (5%), Guillain-Barré syndrome (3%), and idiopathic cavernous sinusitis (3%) 40 (1b). In addition, tumors causing third nerve palsy were more often malignant (58%) versus benign (41%) 40 (1b). Common neoplasms included pituitary adenomas (24%), solid tumor metastases (21%), and lymphomas (16%) 40 (1b) .
Of concern to the otolaryngologist, however exceedingly rare, is the ocular presentation of the sphenoid sinus mucocele. Mucoceles most commonly arise in the frontal sinus followed by the ethmoid, maxillary and, finally, the sphenoid sinus (1% incidence) 41 (3a). Mucoceles in the sphenoid sinus can act as a benign neoplasm, resulting in bony erosion, and they present clinically with symptoms of optic neuropathy 42 (3a), retrobulbar neuritis 43 (3b), blindness 44 (3b), visual impairment 45, 46 (3b, 3b), unilateral abducens palsy, and oculomotor palsy 47 (3a) . This is of note because the diagnosis is primarily radiologic, which is best demonstrated by CT and can be overlooked on MRI 41 (3a) .
Diagnostic principles. Patients with a third cranial nerve palsy will typically complain of eyelid drooping, blurred and/or double vision, and light sensitivity 48 (2a). It is also vital to assess pupillary function. Reported results of patients with confirmed ischemic third nerve palsy show that only 74 to 80% present with normal pupillary function [48] [49] [50] [51] (2a, 1b, 1b, 2b). When incorporating intact pupillary function, the literature has consistently shown that in patients over the age of 50 years with atherosclerotic risk factors, the most likely cause of complete third nerve pupil-sparing palsy is ischemia (followed by trauma and giant cell arteritis) 48,52-55 (2a, 1b, 1b, 3a, 3b). When a patient presents with a complete or incomplete pupil involving third nerve palsy, it is essential to rule out an aneurysm 40, 48, [56] [57] [58] 
Medical imaging. When ischemia is suspected from the physical exam and patient demographics as the etiology of the complete, pupil-sparing third nerve palsy, neuroimaging is not required 48, 59 (2a, 1b). However, patients who develop pupillary involvement or fail to have complete motility involvement should have MRI/ magnetic resonance angiography (MRA). Additionally, patients who do not have resolution of their third nerve palsy after 6 to 8 weeks or show signs of aberrant regeneration should have an MRI/MRA to evaluate for an aneurysm or mass in the subarachnoid area 60 (3b). All children should undergo MRI regardless of pupillary involvement to rule out neoplastic etiologies 48,61 (2a, 1b) .
When there is pupillary involvement in association with third cranial nerve palsy, this warrants urgent MRI/ MRA to rule out a probable aneurysm at the junction of the internal carotid and posterior communicating artery. If these studies are negative, further investigation with CT angiography (CTA) can be pursued in both adults and children 48,62 (2a, 1b) .
In a 2013 prospective study of 112 patients with 134 unruptured aneurysms, Pradilla and colleagues reported specificities as high as 97% for aneurysm detection with CTA and 100% for digital subtraction angiography 48,63-65 (1b, 1b, 1b, 1a). Nonetheless, MRI is commonly recommended because of the range of etiologies (neoplastic, autoimmune) that can affect the third cranial nerve and its greater sensitivity for identifying intracranial pathology compared to CT imaging 61, 66 (1b, 1a).
Summary. Patients over the age of 50 years with atherosclerotic risk factors who present with third cranial nerve palsy and intact pupillary function do not require neuroimaging because the etiology is most likely ischemic and the palsy often tends to resolve completely. Whereas, a patient with a complete or incomplete pupil-involving third nerve palsy, it is essential to rule out an aneurysm with CTA or MRI 40, 48, [56] [57] [58] (1b, 2a, 2b, 1b, 1b). Nonetheless, MRI is commonly recommended because of the range of etiologies (neoplastic, autoimmune) which can affect the third cranial nerve and its greater sensitivity for identifying intracranial pathology compared with CT imaging 61,66 (1b, 1a) .
Conversely, all children presenting with a third cranial nerve palsy should undergo MRI regardless of pupillary involvement to rule out neoplastic etiology 48,61 (2a, 1b) .
Trochlear nerve (IV). The fourth cranial nerve, named after the trochlea, has both a long intracranial course (60 mm) and a very narrow diameter (0.2 to 0.6 mm) 67, 68 (2b, 2b). As a result, this nerve is quite fragile and subject to damage by a variety of processes such as aneurysms, congenital malformations, hydrocephalus, infections, intracranial hemorrhage, ischemia, neoplasms, and trauma. Approximately 37% of cases of neurologically isolated trochlear nerve dysfunction were due to head injury, 32% due to vascular disorders, and 17% secondary to neurosurgical intervention 69,70 (1b, 2a) .
Diagnostic principles. Signs and symptoms of fourth nerve palsy include vertical binocular diplopia with compensatory contralateral head tilt (ocular torticollis), vertical strabismus, and esotropia 71 (4) . Specifically, on ophthalmic examination, the eye will be displaced upward, resulting in a vertical and torsional diplopia, maximal when looking down and usually accompanied by a compensatory head tilt 70 (2a).
guidelines for radiographic iMaging of cranial neuropathies Medical imaging. Unfortunately, isolated paralysis of the trochlear nerve has no neurologic localizing value, and therefore visualization of the complete course of the nerves is indicated 72 (1a) . However, in a study by Murchison and colleagues, only 4.3% of patients had lesions detected on MRI; 1.1% of patients had a lesion directly related to acute ocular motor mononeuropathies 73 (2b) . Hence, in the evaluation of neuropathic strabismus, MRI should ideally be reserved for all patients younger than 50 years with a history of cancer and with multiple cranial neuropathies or evidence of additional neurologic dysfunction.
Imaging should be undertaken in any isolated mononeuropathy that progresses or has not resolved 3 months after the initial visit. While CT imaging is limited because of the small diameter of the fourth cranial nerve, it remains an important diagnostic modality in the evaluation of the intraosseous portions at the skull base and bony foramina 72 (1a). Head trauma leading to isolated fourth cranial nerve palsy is attributed to contusion of the anterior medullary velum or injury to the cisternal segment of the nerve at the free edge of the tentorium 74, 75 (1a, 2b) .
Summary. MRI should be considered in cases of isolated cranial nerve VI neuropathy that has progressed or remains unresolved after 3 months in all age groups. In the evaluation of neuropathic strabismus, MRI should be considered in patients ≤50 years with a history of cancer and with multiple findings of neurologic dysfunction.
Trigeminal nerve (V). Of the cranial nerves, the fifth cranial nerve is the most widely distributed within the suprahyoid neck 76,77 (1a, 1a) . Trigeminal nerve dysfunction may be an isolated neurologic finding or part of a more complex clinical picture. It ranges from common conditions such as classic trigeminal neuralgia (TN) to rare disorders such as trigeminal trophic syndrome and numb chin syndrome.
Other causes of trigeminal nerve dysfunction include infectious, inflammatory, neoplastic, congenital, vascular, and traumatic etiologies. While most of the literature regarding trigeminal nerve dysfunction focuses on common pathologic etiologies (such as TN and trauma) there is a lack of comprehensive studies analyzing other etiologies and syndromes.
Diagnostic principles. In 2004, the International Headache Society (IHS) established a set of guidelines for the diagnosis of both classic and symptomatic TN, which are primarily clinical 78, 79 (1a, 2a). Studies have shown an abnormal trigeminal reflex as a useful clinical finding in distinguishing symptomatic TN from classic TN because of its high specificity (94%) and sensitivity (87%) [80] [81] [82] [83] [84] [85] [86] (1b, 2b, 1b, 1b, 2b, 1b, 1a) .
Additional motor and sensory symptoms of trigeminal nerve palsy include loss of sensation of face (in the V1, V2, V3 distribution) and oral cavity, loss of jaw-jerk reflex (trigeminal reflex), and weakness/paralysis of muscles of mastication 87 (2a) .
Medical imaging. In classic TN, the typical clinical pattern is associated with a normal neurologic and normal MRI examination with no identifiable cause 87 (2a). In a recent set of management guidelines, it was estimated that routine neuroimaging with CT or MRI identifies a lesion, thus separating symptomatic from classic TN, in approximately 15% of cases 86 (1a) . The most common identifiable cause is compression of the trigeminal nerve root by an aberrant loop of a blood vessel, which accounts for about 60 to 90% of cases described in the current literature [88] [89] [90] [91] (1b, 1b, 2a, 1a ). MRI is a valid method to investigate such a cause, although its sensitivity (50 to 95%) and specificity (65 to 100%) is variable throughout studies [92] [93] [94] [95] [96] [97] [98] [99] (3b, 2b, 1c, 1c, 1b, 1c, 1b, 2b).
Additionally, both false-positive rates of 7 to 15% 100,101 (1c, 2b) and a false-negative rate of 10% 99 (2b) have been described 92, [102] [103] [104] (3b, 1b, 1c, 1b ). Furthermore, vascular compression is frequently seen in normal individuals 105 (1b), and the American Academy of Neurology and the European Federation of Neurological Societies (AAN-EFNS) recommendations are inconclusive on the usefulness of these modalities to diagnose vascular compression 86, 94, 95, 100, [106] [107] [108] [109] (1a, 1c, 1c, 1c, 1c, 2b, 1c, 2b) . However, MRI, in cases other than trauma, remains the modality of choice in the detection of trigeminal nerve schwannomas, Meckel cave meningiomas, and perineural spread of tumor, which all initially present with signs of TN.
Diagnosis for TN (classic and symptomatic) is primarily clinical and based on duration and characterization of pain, and on the stereotypical patient. Symptomatic TN requires the presence of a causative lesion, necessitating further evaluation, usually with imaging. Conversely, classic TN does not require additional imaging 86, 110 (1a, 1a). Excluding the acute setting of craniofacial trauma, management recommendations for non-TN fifth cranial nerve palsy are inconclusive on the usefulness of CT/MRI due to the low yield of identifying a causative lesion 86, 93, 95, 100, [106] [107] [108] [109] (1a, 1c, 1c, 1c, 1c, 2b, 1c, 2b) .
Summary. Clinicians do not need to obtain diagnostic imaging (CT/MRI) in cases of classic TN. However, MRI can be used in cases of nontraumatic, non-TN cranial nerve V palsy; clinical judgment should guide the decision.
Abducens nerve (VI). The sixth cranial nerve, a purely somatic cranial nerve, is the most common isolated ocular cranial nerve involved in palsy, with an incidence of 11.3 per 100,000 111 (3b). Approximately 35.9% of cases of neurologically isolated abducens nerve dysfunction were due to vascular disorders, 22.2% to neoplastic disease, 6.8% to head trauma, 6.8% to congenital malformations, and 6.0% to aneurysms 69 (1b).
Diagnostic principles. Signs and symptoms of sixth cranial nerve palsy include ipsilateral eye and brow pain, horizontal diplopia (maximal when gazing in the ipsilateral direction), hypertropia, vertical strabismus, and incomitant esotropia 70, 112 (2a, 1c). In patients over the age of 50 years, a Westergren sedimentation rate and complete blood count can be obtained to evaluate for the possibility of temporal arteritis, as well as to screen for other possible inflammatory etiologies 113 (1a) .
Depending on the diagnostic differential, additional workup in selected patients may include serologies and cerebrospinal fluid (CSF) analysis 70 (2a).
Medical imaging. Regarding the role of neuroimaging of the sixth nerve, a prospective study by Bendszus et al 114 (2b) reveals that in nontraumatic, neurologically isolated cases of acute sixth cranial nerve palsy, a lesion was identified on the initial MRI in 63% of patients. Of these patients in whom lesions were identified, 49% were found to have a neoplastic lesion and 15% were found to have a presumed vasculopathy 114 (2b).
Bendszus et al recommend that MRI imaging be performed routinely in all cases of nontraumatic, isolated acute sixth cranial nerve palsy. However, a recent study has raised issues with the number of neoplastic and positive MRI findings in patients with vasculopathic risk factors and nontraumatic, neurologically isolated sixth cranial nerve palsy 115 (2b).
In general, most patients under the age of 50 years should be evaluated with a contrast-enhanced cranial and orbital MRI. In addition, patients with a history of neoplastic disease should be evaluated with radiographic imaging. If the sixth cranial nerve palsy should progress at any time during follow-up, or if additional neurologic signs or symptoms should manifest, prompt neuroimaging should be performed.
For evaluation of a patient with suspected petrous apicitis (extension of infection from the mastoid air cell tract into a pneumatized anterior or posterior petrous apex) or temporal bone pathology, of concern to the otolaryngologist, high-resolution CT is the most appropriate diagnostic modality due to superior demonstration of bony anatomy. However, MRI is superior in demonstrating CNS anatomy and meningeal enhancement, and in the evaluation of Gradenigo syndrome (clinical triad of retro-orbital pain, sixth cranial nerve paralysis, and otorrhea).
Because of the limited number of reported cases of petrous apicitis or Gradenigo syndrome, there is no clear consensus in terms of the utility of CT vs. MRI. Nonetheless, in cases of temporal bone trauma or pathology (such as Gradenigo syndrome) CT and MRI can be used in concert to better evaluate the extent of bony and intracranial pathology [116] [117] [118] (3b, 3b, 2a) .
Summary. Patients who present with an isolated sixth nerve palsy who are under the age of 50 years, display progression of sixth cranial nerve palsy, have additional neurologic signs/symptoms, or have a history of neoplastic disease should be evaluated with a contrast-enhanced cranial and orbital MRI. There is no clear consensus that MRI is more useful than CT imaging in cases of petrous apicitis.
Facial nerve (VII). There are numerous etiologies of facial nerve palsy, though hemifacial weakness is often generally termed Bell palsy, named after the Scottish neurologist Sir Charles Bell, who described the sudden onset of unilateral facial nerve paralysis in 1821 119 (3a) . Today, Bell palsy refers to acute idiopathic facial nerve palsy without an identifiable cause, but current thought is that this condition is virally induced.
Injuries to the facial nerve produce a combination of functional, aesthetic, and psychologic problems for the patient. There are many etiologies of facial nerve palsy, ranging from infectious, inflammatory, neoplastic, traumatic, and vascular mechanisms. However, multiple studies have consistently shown Bell palsy to account for the greatest number of cases [119] [120] [121] [122] [123] (3a, 3a, 1b, 1c,  1c) . Studies report the incidence of Bell palsy to range from 38% 119 (3a) to 70% 124 (1a) of all cases of facial nerve palsy. Approximately, 11.5 to 53.3 per 100,000 persons per year [119] [120] [121] [122] [123] (3a, 3a, 1b, 1c, 1c ) are affected yearly with Bell palsy, with no predilection for either sex or side of the face 120 (3a).
In a 2002 study of 2,500 patients 121 (1b), Bell palsy is the most common etiology, followed by congenital cases, Varicella zoster-associated facial nerve palsy, and traumatic palsy as the next most common causes of facial nerve palsy.
Diagnostic principles. Bell palsy remains a diagnosis of exclusion; hence, it is imperative to decrease the likelihood of misdiagnosis. A comprehensive history should look for symptoms such as dizziness, dysphagia, or diplopia, additional otologic symptoms, facial or ear pain, and symptoms concerning for multiple cranial nerve neuropathies that suggest diagnoses other than Bell palsy.
The timing of the onset of symptoms remains important. Symptoms associated with neoplastic or infectious causes of facial paralysis often progress gradually, relative to the sudden-onset characteristic of Bell palsy 125 (1a). Nonetheless, laboratory testing is not indicated guidelines for radiographic iMaging of cranial neuropathies when history and physical examination do not suggest an alternative cause 124 (1a) .
Medical imaging. Clinicians do not routinely perform diagnostic imaging for patients with an isolated, new-onset facial nerve palsy that develops in <3 days because most cases are Bell palsy. MRI studies of Bell palsy may commonly show enhancement along the involved (ipsilateral) facial nerve, especially around the area of the geniculate ganglion (21% of normal controls versus 91% of patients with Bell palsy) 126 (1c). However, this finding does not influence the course of therapy. In fact, this enhancement may be confused with another process such as a small tumor of the facial nerve or other incidental findings, leading to further unnecessary testing [126] [127] [128] [129] (1c, 1a, 3a, 1a) .
If history or physical exam suggests an alternate diagnosis from Bell palsy (trauma to the temporal bone or slow onset of symptoms, a palpable mass suggestive of neoplasia, or paralysis THAT fails to recover or worsens within 3 months), the literature supports further evaluation with MRI as the imaging test of choice 124, [130] [131] [132] (1a, 3a, 2b, 3a) . Imaging should include both the internal auditory canal (IAC) and face, such that the whole course of the facial nerve is included.
In a 2002 study of 147 patients with facial nerve palsy and 300 control cases, Kinoshita et al showed the intrameatal and labyrinthine segments of the normal facial nerve did not show enhancement, whereas enhancement of the distal intrameatal segment and the labyrinthine segment, respectively, was found in 67 and 43%, respectively, of patients with facial nerve palsy 126 (1c) . Hence, enhancement of the distal intrameatal and labyrinthine segments is specific for facial nerve palsy. If an MRI is contraindicated, a contrast-enhanced CT can be used 124, 132, 133 (1a, 3a, 1a) .
Summary. Clinicians should not obtain routine laboratory testing, diagnostic imaging, or electrodiagnostic testing in patients with idiopathic facial nerve palsy that develops acutely (over 72 hours) and is characteristic of Bell palsy. However, the literature strongly suggests that any presentation of facial paralysis inconsistent with Bell palsy should be further evaluated by imaging 124,129 (1a, 3a) , such as in the case of bilateral facial paralysis, multiple cranial nerve deficits or in the setting of acute craniofacial trauma additional imaging 124 (1a) . MRI of the entire course of the facial nerve, including both the IAC and face, with and without contrast, is the imaging test of choice for patients in these circumstances 124 (1a) .
Vestibulocochlear nerve (VIII). The eighth cranial nerve is a sensory nerve that conducts the two special senses: hearing (audition) and balance. Recent estimates reveal that 34.25 million people have some degree of hearing loss in the United States, placing significant focus on inner ear pathology as the numbers continue to increase. Furthermore, hearing loss can be classified into two distinct categories, conductive hearing loss (CHL) and sensorineural hearing loss (SNHL). CHL occurs when sound is not adequately transferred to a functioning cochlea and can occur because of dysfunction of the external auditory canal, the tympanic membrane, or the ossicles.
Causes of CHL are varied and may be categorized by location. External ear pathology includes impacted cerumen or foreign bodies, congenital canal atresia, inflammatory stenosis with acquired atresia, and bony exostoses. Any mechanism that prevents the proper vibration of the tympanic membrane (TM) can lead to CHL (TM perforation, scarring of the TM, tympanosclerosis, or middle ear effusions).
Diagnostic principles. Classic signs and symptoms of eighth cranial nerve palsy include deafness, tinnitus, vertigo, unsteady gait, and nystagmus. Audiometry is mandatory for definitively diagnosing sudden SNHL because it distinguishes CHL from SNHL and establishes frequency-specific hearing thresholds. Varying criteria have been used in the literature to diagnose sudden SNHL, but a hearing loss of ≥30 dB at three consecutive frequencies is the definition adopted by the National Institute on Deafness and Other Communication Disorders and the definition used in most randomized clinical trials [134] [135] [136] [137] (1b, 1a, 1b, 1a) .
Clinicians do obtain routine laboratory tests in patients with idiopathic sudden SNHL. There is no evidence to support a shotgun approach to serologic testing for patients with SSNHL, however, because the positive yield of such testing remains unfavorably low 135, 137, 138 (1a, 1a, 3b) .
Medical imaging. Clinicians can evaluate patients with idiopathic sudden SNHL for retrocochlear pathology by obtaining an MRI, auditory brainstem response (ABR), or audiometric follow-up. Retrocochlear pathology is defined as a structural lesion of the vestibulocochlear nerve, brainstem, or brain. As many as 10 to 20% of patients with a vestibular schwannoma will report a sudden decrease of hearing at some point in their history 139 (3b) .
Additionally, several studies demonstrate a relatively high prevalence of cerebellopontine angle (CPA) tumors in SNHL patients, ranging from 2.7 to 10.2% of patients who are evaluated with MRI [140] [141] [142] [143] [144] [145] (1b, 3b, 3b, 2b, 1b,  3b ). Testing with MRI, ABR, or follow-up audiometry is important for detecting vestibular schwannoma because no clinical features can reliably distinguish sudden SNHL caused by an underlying tumor from the more common idiopathic variety 141 (2b) .
MRI is the gold standard for vestibular schwannoma diagnosis and is more cost-effective than ABR followed by MRI 146 (2c). The sensitivity of MRI with gadolinium khaku, patel, zacharia, goldenBerg, Mcginn in the diagnosis of a vestibular schwannoma larger than 3 mm approaches nearly 100% 146, 147 (2c, 1b) . Contrast-enhanced MRI can identify an abnormality in 10.7 to 57% of patients with sudden SNHL, such as a CPA tumor, labyrinthine hemorrhage, cerebrovascular accident, or demyelinating process 140, [148] [149] [150] (1b, 3b, 3b, 3b) .
The overall rate of pathogenic MRI abnormalities directly related to sudden SNHL ranges from 7 to 13.75%. 60, 98 Therefore, MRI has the highest yield of any diagnostic test in the setting of sudden SNHL 135 (1a) .
According to the evidence-based American College of Radiology's Appropriateness Criteria panel, in the scenario of acute hearing loss and vertigo,a head CT with or without contrast is unlikely to be indicated, or the risk-benefit ratio for the patient is likely to be unfavorable 151 (1a). In the current guidelines, the authoring panel would assume that the history and physical examination would have determined whether a cholesteatoma or other pathologic condition was present and, if so, a targeted temporal bone CT would then be more appropriate 135 (1a) .
Summary. In the case of asymmetric SNHL, gadolinium-contrast-enhanced T1-weighted magnetic resonance imaging (GdT1W MRI) is the most widely accepted evaluation for asymmetric SNHL and has replaced ABR and CT imaging as the initial screening test to detect anatomic abnormalities such as acoustic neuromas (ANs). However, recently it has been shown that nonenhanced fast spin-echo T2-weighted (FSE T2W) MRIs targeted to the IAC/CPA can be used as an initial imaging modality to rule out anatomic abnormalities in SNHL because it is rapid, cost-effective, and has a sensitivity 98% for acoustic tumors. Unfortunately, FSE T2W MRIs are not as effective as GdT1W MRIs in detecting small acoustic neuromas, labyrinthine ANs, and inflammatory disorders 152 (1a) . In general, MRI should be used to evaluate SNHL while CT should be used to evaluate CHL 153 (1a) .
Glossopharyngeal nerve (IX). Pathologic conditions affecting the ninth cranial nerve in isolation are rare 154 (4) . However, they can be divided into a primary (idiopathic) type or a secondary/symptomatic type, for which a cause can be identified (trauma, inflammation, vascular deformities, aneurysms, or neoplasms) 154, 155 (4, 1a) . Infectious diseases, including carotid sheath abscesses and deep neck infections along the cranial nerve pathways, can also lead to cranial nerve involvement 156,157 (3b, 1a) .
Glossopharyngeal neuralgia (GPN), thought to result from artery-nerve conflict between the ninth cranial nerve and posterior inferior cerebellar artery (PICA) 158, 159 (1a, 3b), is a paroxysmal pain condition that is characterized by pain in the throat, pharynx, and ears and is often associated with TN. Approximately 11% of patients with GPN have associated TN 155, 158, 160, 161 (1a, 1a, 3b, 3b ).
An interesting cause of secondary GPN is compression of the nerve by an elongated styloid process, the so-called "Eagle syndrome." Eagle syndrome resembles primary GPN; however, in most cases the pain is more constant and dull in character 162 (3a) . The reported epidemiologic incidence of Eagle syndrome varies from 4 to 7%. Nonetheless, only a small percentage of patients have symptoms of pain 158, 163, 164 (1a, 3a, 3b) .
Diagnostic principles. The clinical signs of isolated glossopharyngeal neuropathy are rare; they include external otalgia, slight dysphagia, loss of the gag reflex on the ipsilateral side, contralateral deviation of the uvula, and changes in taste from the posterior onethird of the tongue (ageusia) 154, 158, 165, 166 (4, 1a, 2a, 2a) . Additionally, isolated glossopharyngeal neuropathy can include abolition of the velopalatine reflexes 158 (1a) .
Medical imaging. GPN, if suspected, is best appreciated by a high-resolution T2-weighted MRI sequence. It helps reveal the contact between the glossopharyngeal nerve and an artery, most commonly the PICA. Other sequences (volume T1-weighted gradient echo, timeof-flight MRA) are complementary and can be used to eliminate alternative diagnoses 158, 165, 167 (1a, 2a, 3a) .
The evaluation of Eagle syndrome is best performed by CT, which demonstrates calcification or ossification of the stylohyoid ligament and the "elongated styloid" process. The diagnosis of Eagle syndrome is one of exclusion and is confirmed by CT imaging 156,157 (3b, 1a) .
Summary. Currently no recommendation can be given for the evaluation of suspected GPN with T2 MRI.
Vagus nerve (X). The tenth cranial nerve is the longest of the cranial nerves, traveling from the posterior skull base to the abdominal viscera 157 (1a) . Two different patterns of denervation can be recognized on imaging, helping to localize the offending lesion 168-171 (3b, 3a, 1a, 1a) . A proximal pattern, in which the pharyngeal plexus and both laryngeal nerves are affected, manifests clinically by difficulty in swallowing, hoarseness, and dyspnea and implies a lesion above the level of the hyoid bone; a distal pattern manifests as isolated neuropathy of the superior laryngeal or recurrent laryngeal nerves [168] [169] [170] [171] (3b, 3a, 1a, 1a ).
Pathologic conditions resulting in proximal vagal nerve injury commonly manifest as multiple lower cranial neuropathies. Proximal vagal nerve palsy etiologies include stroke (Wallenberg syndrome) and benign neoplasms (schwannomas, neurofibromas, and paragangliomas) 165, 172 (2a, 2a). Etiologies of distal or recurrent laryngeal nerve palsy include tumors (32%), surgery (30%), idiopathic causes (16%), trauma (11%), central nervous system pathology (8%), and infection (3%) 173 (2c) .
In a study by Benninger et al of 396 patients identified with immobile vocal folds, 67 unilateral immobile vocal folds were secondary to surgical trauma with only guidelines for radiographic iMaging of cranial neuropathies 33.3% of these due to thyroidectomy 174 (3b) . In contrast to unilateral vocal fold paralysis (UVFP), surgical trauma and thyroidectomy resulted in most of the bilateral surgically related incidents.
Fortunately, the incidence of transient recurrent laryngeal nerve palsy is more common than permanent injury, with rates varying from 1.8 to 20% 175 (2b) . Due to its longer anatomic course and its extension into the mediastinum, the left side is more often affected than the right side (52.5% of the unilateral peripheral neuropathies). In addition, peripheral vocal fold paralysis tends to be more common than central paralysis, with only 10% of cases identified as central in nature 176 (3b) .
A proximal or central pattern, in which the pharyngeal plexus and both laryngeal nerves are affected, which manifests clinically by difficulty in swallowing, hoarseness, and dyspnea, implies a lesion above the level of the hyoid bone; a distal or peripheral pattern commonly manifests as an isolated neuropathy of the superior laryngeal or recurrent laryngeal nerves 171 (1a). Unfortunately, a causative lesion is often not identified along the course of the recurrent laryngeal nerve in 85% of cases 165, 170, 176 (2a, 1a, 3b) .
Diagnostic principles. Clinical symptoms related to vagal neuropathies include abnormal gag reflex, uvular deviation, hoarseness, aspiration due to vocal fold malfunction, and dysphagia. Indirect mirror laryngoscopy must be done to evaluate gross vocal fold mobility and to look for the presence of pooled secretions 177 (1a) .
In a survey of 63 patients with UVFP, all patients reported voice problems, 60% reported swallowing problems, and 75% reported dyspnea. In patients with dysphagia and UVFP who underwent flexible endoscopic evaluation of swallowing studies, liquid bolus retention and penetration were associated with aspiration in nearly 50% of patients 178,179 (1b, 1b) .
Medical imaging. A variety of imaging techniques (chest x-ray, CT, and MRI) commonly have been used in the workup of patients with suspected UVFP. Altman and Benninger described beginning with chest x-ray and proceeding with CT or MRI if the x-ray is negative. 180 
The CT is performed from skull base to thoracic inlet for a right UVFP, and skull base to aortic triangle for a left UVFP. In contrast, El Badawey described primary use of CT, without routine use of chest x-ray; they state, "CT scan for unexplained vocal cord paralysis is efficient to detect any significant neoplastic pathology" 181 (2b) The role of MRI and vocal fold paralysis when mediastinal disease is suspected also remains unclear. It has been suggested that MRI is more sensitive than CT, but carries a higher rate of false-positives 182 (3b). However, if a high vagal palsy is suspected (sternocleidomastoid and trapezius atrophy, atrophy and ballooning of the middle and inferior constrictors, cricothyroid atrophy, and tilting of the thyroid cartilage in addition to common vocal fold paralysis features), then MRI should be strongly considered to investigate a skull base or intracranial cause 183 (1a) .
According to the European Federation of Neurological Societies guidelines, patients who present with a polycranial nerve neuropathy or a distal vagal nerve palsy and a history of cancer known to frequently metastasize to the brain (lung 50%, breast 15 to 25%, and melanoma 5 to 20%) should be evaluated with a full CNS MRI 184 (1a). MRI is preferred in this context because of its multiplanar imaging capability and superior separation of soft tissues in this region 177, 185 (1a, 3b) .
Summary. It is strongly recommended that clinicians obtain full CNS evaluation with MRI in cases of polycranial nerve neuropathy or distal vagal nerve palsy in a patient with a history of cancer 177, 184, 185 (1a, 1a 3b ). If the clinicians suspect a high vagal palsy, MRI should be strongly considered to investigate a skull base or intracranial cause 183 (1a). However, the role of MRI in unilateral vocal fold paralysis when mediastinal disease is suspected remains unclear and is left to clinical judgment. CT of the neck and upper chest (through the aortic arch) is recommended for evaluation of idiopathic UVFP 181 (2b).
Accessory nerve (XI). The eleventh cranial nerve is purely motor in nature and provides innervation to both the sternocleidomastoid and trapezius muscles 165, 166 (2a, 2a). The most common etiology for accessory denervation is neck dissection for treatment of aerodigestive tract carcinomas. Rare cases of paroxysmal torticollis due to vascular compression of the accessory nerve have been reported, as well 186,187 (2a, 1a) . Nonetheless, 71% of accessory nerve injuries are found to be iatrogenic in nature, and 24% traumatic in etiology 188 (3b).
Diagnostic principles. A paralysis of the accessory nerve can be clinically diagnosed by resultant shoulder droop secondary to trapezius muscle denervation 165, 166 (2a, 2a), diminished strength on turning the head toward the paralyzed side 165, 166 (2a, 2a), and weakness in elevating the shoulder above the horizontal plane 165,166 (2a, 2a) . Noniatrogenic impairment is rare and will induce paralysis of both the sternocleidomastoid and trapezius muscle.
Medical imaging. In most cases, injury to the spinal accessory nerve is iatrogenic or traumatic, such as in the case of radical neck dissection. Therefore, the diagnostic value of medical imaging remains limited in cases of spinal accessory nerve palsy. However, if a neoplastic process is suspected, or if it is needed to monitor for recurrence, imaging is necessary as clinically appropriate for the suspected neoplasm 165, 166, 189 (2a, 2a, 3b).
Summary. While no clinical recommendation can be given today in evaluating an eleventh cranial nerve khaku, patel, zacharia, goldenBerg, Mcginn injury, imaging is necessary as clinically appropriate if a neoplastic process is suspected or to monitor for recurrence 165,166,189 (2a, 2a, 3b) .
Hypoglossal nerve (XII). The twelfth cranial nerve supplies motor innervation to the tongue and contributes to the innervation of the infrahyoid strap muscles through the ansa hypoglossi 158,165 (2a, 1a) . Causes of pathology include neoplasia (49%), trauma (12%), autoimmune (9%), vascular (6%), and infectious (4%) [190] [191] [192] (1a, 3b, 1a). The involvement of the distal branches of the hypoglossal nerves is most often due to malignant tumors arising in the floor of the mouth and the sublingual space 158,166 (1a, 2a) .
Traumatic injury of the lower cranial nerves is most often iatrogenic (i.e., neck dissection). In one study of 442 patients conducted by Prim et al, hypoglossal nerve paralysis occurred after functional neck dissection in 3 cases (0.42%) 193 (3b). Traumatic injury can be associated with fractures or dislocations affecting the posterior skull base or craniovertebral junction, crossing the jugular foramen, condylar canal, or occipital condyles 169, 194, 195 (3a, 3a, 3b). The cranial nerve palsy may not be present immediately but be delayed 157, 165, 196, 197 (1a, 2a, 1a, 2a) .
Diagnostic principles. Patients with hypoglossal paralysis present clinically with dysarthria, ipsilateral tongue paralysis, and fasciculation. Approximately 4 to 6 weeks after injury, the intrinsic and extrinsic muscles of the tongue undergo atrophy 158, 165, 166, 198 (1a, 2a, 2a, 3b ).
Medical imaging. By itself, the clinical examination cannot localize with accuracy the site of damage to the nerve. Conventional radiology and ultrasound are insufficient and today the diagnostic approach for hypoglossal nerve dysfunction, as in the case of other cranial nerves, relies on CT and MRI. MRI is superior in visualizing the nerve proper, rootlets, and branches, whereas CT easily displays the hypoglossal canal and the state of the neighboring foramina and osseous segments of the skull base, information that is especially relevant to preoperative planning. MRI provides exquisite soft-tissue contrast, allows direct visualization of the different segments of the nerve, and is generally the imaging method of choice for hypoglossal nerve palsy of unknown etiology 165, 167, 192, 199 (2a, 3a, 1a, 3a).
Regardless of the imaging technique, the entire anatomic course of the nerve should always be covered with the obligatory use of intravenous contrast. This is essential for a full picture of the different segments of the nerve and to accurately map the offending lesion, but it is especially important when one is staging a head and neck malignancy 192 (1a) . MRA is recommended when there are concerns for hypoglossal nerve palsy secondary to aneurysms of the vertebral artery (VA) and the PICA, and vascular malformations within the cisterns 200 (3a) . Isolated hypoglossal palsy has been reported in association with internal carotid artery and VA dissection 158, 165, 201 (1a, 2a, 3b ).
Summary. Clinicians may consider the use of contrast-enhanced MRI to evaluate the entire course of the twelfth cranial nerve in cases of isolated hypoglossal nerve palsy. Furthermore, MRI is generally the imaging method of choice for hypoglossal nerve palsy of unknown etiology 165, 167, 192, 199 (2a, 3a, 1a, 3a) .
Conclusion
Cranial neuropathies can result from a wide range of etiologies, from infectious, neoplastic, inflammatory, and traumatic pathologies. Furthermore, disruption of these complex pathways can occur at any site along their respective anatomic courses, resulting in many pathologic processes. Therefore, the necessity and modality of medical imaging varies between the specific cranial neuropathy and its respective clinical setting. In some instances, such as trauma, the imaging modality of choice is often clear (CT). However, in other clinical scenarios, the optimal imaging modality is not as certain. This contributes to the initial presentation of cranial neuropathy to a wide range of medical and/ or surgical specialties.
We sought to combine primary research and best-practice recommendations across all medical specialties to create a practical framework for the radiographic evaluation of cranial neuropathies. Our results and recommendations are summarized in table 2. This review can serve as an evidence-based reference to assist the physician encountering cranial neuropathies in practice, with a consolidated review of available literature and recommendations gleaned from their review. It is not intended to serve as a clinical practice guideline (CPG) and does not carry the high-level scrutiny and widespread stakeholder input necessary for a CPG.
